Literature DB >> 20333603

[Health economic impact of heart failure: An analysis of the nationwide German database].

C Zugck1, A Müller, T M Helms, H J Wildau, T Becks, J Hacker, S Haag, K Goldhagen, J O Schwab.   

Abstract

BACKGROUND AND AIMS: Patients with congestive heart failure represent a significant amount of the total annual cost of the health care system. Because of a lack of studies on the economic health cost of the related health care, including all cost generating factors, we analysed in detail characteristics of these patients and the costs created by their care.
METHOD: Data were retrieved from the German Bureau of Health Statistics for the year 2002 relating to congestive heart failure (Code I50) including other factors (e. g. co-morbidities, ambulatory and hospital care and choice of the doctor). The data were from more than 2 million patients, from 350 insurance companies, the Federal Employees Insurance and the German Institute for Medical Informatics and Documentation. A total of 86 193 patients with congestive heart failure had been recorded.
RESULTS: More women than men were recorded as having congestive heart failure (66 vs. 34 %). The various health insurance companies paid 2.3 times more for patients with than without congestive heart failure. Nearly three quarters of the cost for these patients (72 %) resulted from in-patient care. Moreover, costs for drugs were three times higher (1073 Euro vs. 366 Euro).
CONCLUSIONS: This analysis clearly demonstrates the increased costs incurred for patients with congestive heart failure. It should serve as a reference base for better assessing future innovations, such as telemedicine, for their effects in different sectors of health care. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Year:  2010        PMID: 20333603     DOI: 10.1055/s-0030-1251912

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  7 in total

1.  [Telemonitoring in heart failure : Update on health-related and economic implications].

Authors:  L Diedrich; C Dockweiler; A Kupitz; C Hornberg
Journal:  Herz       Date:  2017-06-07       Impact factor: 1.443

2.  [Impact of guideline adherence on mortality in treatment of left heart failure].

Authors:  S Neubauer; T Schilling; J Zeidler; A Lange; S Engel; R Linder; F Verheyen; J-M Graf von der Schulenburg; A Haverich
Journal:  Herz       Date:  2016-02-16       Impact factor: 1.443

3.  Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany.

Authors:  Ulrike Theidel; Saku Väätäinen; Janne Martikainen; Erkki Soini; Thomas Hardt; Wolfram Doehner
Journal:  ESC Heart Fail       Date:  2017-07-03

4.  Retrospective analysis into differences in heart failure patients with and without iron deficiency or anaemia.

Authors:  Christian Jacob; Julia Altevers; Isabella Barck; Thomas Hardt; Sebastian Braun; Wolfgang Greiner
Journal:  ESC Heart Fail       Date:  2019-07-09

Review 5.  Heart failure in South Asia.

Authors:  Harikrishnan Sivadasan Pillai; Sanjay Ganapathi
Journal:  Curr Cardiol Rev       Date:  2013-05

6.  Telemedical monitoring of patients with chronic heart failure has a positive effect on total health costs.

Authors:  Robert Herold; Wolfgang Hoffmann; Neeltje van den Berg
Journal:  BMC Health Serv Res       Date:  2018-04-10       Impact factor: 2.655

7.  Cost-of-illness studies in heart failure: a systematic review 2004-2016.

Authors:  Wladimir Lesyuk; Christine Kriza; Peter Kolominsky-Rabas
Journal:  BMC Cardiovasc Disord       Date:  2018-05-02       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.